We have waited more than a decade for this: ROAM is presented in Rome! See the results of ROAM/EORTC-1308, now also published in @thelancet.com! www.thelancet.com/journals/lan... @eanoassociation.bsky.social @mj-mair.bsky.social @maxmastall.bsky.social @galldiks.bsky.social @rdepietro.bsky.social

What a start to this year’s #EANO in the eternal city - the education day, the EANO Youngsters Pro/Con session, and the welcome reception were amazing! @eanoassociation.bsky.social @mj-mair.bsky.social @maxmastall.bsky.social @galldiks.bsky.social @rdepietro.bsky.social

📸 ATTRACT General Assembly & Retreat - great discussions, clear priorities, and exciting next steps ahead 🚀 Proud of our interdisciplinary team driving precision oncology forward. #NeuroOncology #ClinicalTrials #CancerResearch #btsm #glioblastoma

🎄 Festive publication alert from ATTRACT 💫 Our new review in #CancerTreatmentReviews highlights how ex vivo drug screening can support #FunctionalPrecisionOncology and inform #ClinicalTrials like ATTRACT. doi.org/10.1016/j.ct... ✨ Wishing all a warm and restful holiday season - see you in 2026!

Ex vivo drug screening on patient-derived tumor material to advance functional precision in oncology: an overview on current approaches and unresolved challenges

Over the past two decades, oncology has undergone a profound transformation, largely driven by the rise of targeted therapies and immune-modulating agents. By tailoring treatments to the molecular pro...

cancertreatmentreviews.com

That’s a wrap on WFNOS/SNO 2025 in Honolulu, Hawaii! The #EANO team truly enjoyed connecting with colleagues from around the world, exchanging insights, and celebrating SNO’s 30th anniversary. A big thank you to the @neuroonc.bsky.social for hosting this inspiring meeting! 🌺 #SNO2025 #WFNOS2025

Back to cold Vienna 🥶 after #SNO2025 #WFNOS2025 in Honolulu! 🌺🏝️ Great talks, inspiring discussions, presenting own data, catching up with friends & colleagues - all made even better by Hawaiian sunshine. 😎 Last conference of 2025 in the books. Looking forward to what’s next in 2026! 🚀 #btsm

🧠 Thank you for joining us at the recent #EANOYoungsters Journal Club session: Lighting up PET imaging in IDH mutant gliomas 👉 Missed the latest session? No worries – you can catch up by watching the recording on YouTube: youtu.be/0i9XVEjDs5c?... We look forward to seeing you at our next session!

Excited to be part of this session! 🔬🧠🚀 Looking forward to great discussions at the EANO Youngsters Journal Club - also open to the young-at-heart 😉 @eanoassociation.bsky.social

EANO@eanoassociation.bsky.social · 11mo ago

🧠 Join the next #EANO Youngsters Journal Club! Upcoming session: “Lighting up PET imaging in IDH mutant glioma” [Mair, M., Werner, J. M., Weller, J., et al. (2025), doi.org/10.1093/neuo... 🗓 November 11, 2025 | 🕓 16:30–17:30 CET 👥 Open to all EANO members | Free of charge 🔗 Learn more: www.eano.eu

🧠 Join the next #EANO Youngsters Journal Club! Upcoming session: “Lighting up PET imaging in IDH mutant glioma” [Mair, M., Werner, J. M., Weller, J., et al. (2025), doi.org/10.1093/neuo... 🗓 November 11, 2025 | 🕓 16:30–17:30 CET 👥 Open to all EANO members | Free of charge 🔗 Learn more: www.eano.eu

We had a brilliant #EANO2025 Youngsters and CBI session with countless helpful tricks for young investigators! @eanoassociation.bsky.social @maxmastall.bsky.social @mj-mair.bsky.social @galldiks.bsky.social @profajchalmers.bsky.social

The next day of #EANO2025 starts with many valuable insights from the EANO Youngsters-EORTC session on clinical trials! @eanoassociation.bsky.social

🧠 Great exchange at our EANO Youngsters - EORTC Joint session at #EANO2025! 🚀 We discussed how collaboration through EORTC supports early-career investigators - and vice versa - plus insights into current brain tumor trials. Thanks @eortc.org & @eanoassociation.bsky.social! #NeuroOncology #btsm

Still 2 days to #EANO2025! Congratulations to @martinvandenbent.bsky.social, selected for the Best Oral Presentation Award in Clinical research! He’ll present results of the @eortc.org #CATNON trial in Session OS04 on Sat, Oct 18. 👉 www.eano.eu/eano2025/pro... #BrainTumor #btsm

Make the most of #EANO2025 – download the official Congress App! Access the full programme, plan your sessions, connect with fellow attendees, and stay up to date throughout the event. 🔗 Get started: www.eano.eu/eano2025/myc... #NeuroOncology #BrainTumor #btsm #Prague2025

It's #AHPDay2025 and we are very proud to have so many different professions represented at #EANO. Are you a Nurse or Allied Healthcare Professional in Neuro-oncology? Join us! 👉 www.eano.eu/about/about-... 👉 www.linkedin.com/groups/12675... Or meet us in person at #EANO2025 in Prague!

🎉 Congrats to Irma Sakic (UZH) on receiving the #EANO2025 Best Oral Presentation Award in Basic research! She'll present her work on #CRISPR screening & #glioblastoma in KS01, Oct 17. Learn more and check the full programme 👉 www.eano.eu/eano2025/pro... #btsm #NeuroOncology

Still 3 days to #EANO2025 – and here’s another highlight: Maxine Gorter from @amsterdamumc.bsky.social receives the Best Oral Presentation Award in Supportive care & quality of life research. Congrats! 🎉 🧠 OS01 | Fri, Oct 17 👉 Full programme: www.eano.eu/eano2025/pro... #NeuroOncology #btsm

#EANO2025 in Prague is just around the corner! Congrats to Darui Jin from @dkfz.bsky.social, recipient of the Best Oral Presentation Award in Translational Research. Catch the talk in OS12 on Sun, Oct 19: “AI-based histopathological classification...”👉 t1p.de/EANO2025-OS12 #NeuroOncology #AI #btsm

👉 We are excited to announce that the #EANO2025 Abstract Book is now available online! Download & explore it today: lnkd.in/dg79p6wM #AbstractBook #NeuroOncology #neurosurgery #cancernurse #neuropathology #radiotherapy #AHP #btsm

🧠 Treating #IDHmutant #glioma can be tricky - watch-and-wait, #vorasidenib, or radiochemo? 🤔 📚 Our new paper in #NeuroOncology shows amino acid #PET adds prognostic value in a large bi-centric cohort (n=457) at @lmu-klinikum.bsky.social & @meduniwien.ac.at. [1/2] doi.org/p382

Prognostic stratification of newly diagnosed IDH-mutant gliomas by [18F]fluoroethyltyrosine and [11C]methionine PET – a retrospective, bicentric cohort study

AbstractBackground. Improved prognostic stratification including imaging-based parameters is needed to guide treatment decisions in IDH-mutant glioma.Metho

doi.org

🚀 #ATTRACT is growing! ⛔️ #ClinicalTrials shouldn’t be limited to a few centers. Therefore, we are expanding our #biobanking to give #glioblastoma patients across #Austria 🇦🇹 access to ATTRACT. 🎉 Milestone: 1st patient enrolled in Wiener Neustadt! #NeuroOncology #PrecisionMedicine #CancerResearch

🧠 Just published in @thelancetoncol.bsky.social: Updated RANO and EANO recommendations on the clinical use of PET imaging in gliomas. 🔗 Read more: www.thelancet.com/journals/lan... #NeuroOncology #Glioma #PETimaging #EANO #RANO #BrainTumor #LancetOncology

🧠 What is #ATTRACT – and how could it improve #glioblastoma care? This video (🇩🇪 with 🇬🇧 subs) explains how we test 28 drugs on tumor cells & personalize therapy. Made by @lbg.ac.at w/ Anna Berghoff (ATTRACT Head), @mj-mair.bsky.social (Deputy Head) & Matthias Preusser (Mentor) 🚀 youtu.be/NfxxMZ_xmF4

Die KFG ATTRACT

YouTube video by Ludwig Boltzmann Gesellschaft

youtu.be

🚀🧠 Exciting science ahead 🔬- follow us for further updates and insights! #glioma #glioblastoma #clinicaltrial #research #btsm #neurooncology #precisionmedicine #oncology

ATTRACT - Clinical Research Group@attract-crg.bsky.social · last yr.

🚀 We’re launching the BlueSky presence of #ATTRACT - a 🇦🇹 Clinical Research Group investigating ex-vivo drug screening 💊 for personalized #glioblastoma treatment, funded by @lbg.ac.at with @meduniwien.ac.at as lead institution. ➡️ Follow us for further insights! 🧠 #GlioblastomaAwarenessDay #NeuroOnc

🧠 New EORTC survey shows PET imaging is widely available and used across European brain tumour centres. With data from 103 centres in 20 countries, the findings support PET-based endpoints in future trials. 🔗 Find out more: www.eortc.org/blog/2025/07... #EORTCbrain #PETImaging

Live from @nmnsymposium.bsky.social in Vienna: introduction of first RANO criteria for response assessment of brain metastases based on amino acid PET - with simultaneous publication in Nature Medicine. Learn more: www.nature.com/articles/s41... #braincancer #PETimaging

Are you making an impact in #NeuroOncology research? The #EANOResearchAward honors outstanding contributions in the field. Apply now for a chance to be recognized at #EANO2025 in Prague! 📝 Nomination deadline: May 15 📩 Send your application to: awards@eano.eu Learn more: www.eano.eu #EANO #btsm

📢 Early Bird Registration open until tomorrow for #NMN2025- register today: www.nmn-society.org/registration/!

Registration

Registration for the NMN Symposium 2025 is OPEN! Regsitration Fees Early Fee* until February 28, 2025 Late Fee until May 05, 2025 Onsite Fee May

nmn-society.org

Nuclear Medicine and Neurooncology (NMN)@nmnsymposium.bsky.social · 2y ago

⚠️Register today for #NMN2025: nmn-society.org/registration/!

1/3 Excited to share two recent publications! 🧠💡 First, we explored radioligand target expression in high-grade #meningioma, finding #SSTR2a and #FAP variably expressed, with implications for patient selection and radioligand therapy design. @nathaliealbert.bsky.social doi.org/n786

Expression of SSTR2a, FAP, HER2 and HER3 as potential radionuclide therapy targets in higher-grade meningioma - European Journal of Nuclear Medicine and Molecular Imaging

Purpose High-grade meningiomas have high recurrence rates and limited prognosis. Radioligand therapies are approved in extracranial malignancies, but their value in brain tumours including meningiomas...

doi.org

🤩WOW! A total of 60 abstracts from 18 countries from all around the globe were submitted for #NMN2025! Cutting edge research on gliomas, meningiomas, brain metastases that will advance #PET imaging and #theranostics! Register today and join us: nmn-society.org/registration/!